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II has been kncwn for many years [bat acetylcboline is B 
potent vawdilator in viva but fails to consistently relax 
is&ted vaxular strips in vitro. These divergent obscrw 
t&l: were resolved in 1980 when Furcbgott and Zawadrki 
(1) demonstrated that. vascular relaxation due to acetykbo- 
line required the presence of intact endathelium. Until that 
time, exwimenls using in vitro va~colar ings had often 
stripped off the endothelium in the preparation Process. 
Furchgott and Zawadzki sugested that endothelial cells 
release D smooth muscle relaxing substance when somutated 
by acetylcholine. The term endothelium-derived relaxin& 
factor WPL intmduced in 1983 (2). 
The known role of endotheliwderived relaxing factor 
has expanded, and vawlar relaxation induced by a large 
number of vasoaclive swbstanccs is now understood tu be 
dependent oo this factor. TheJe vamactive substances to- 
dude bradykinin. vasoactive intestinal peptide. calcitonin 
gene-related pcptide. adenine nuckotides. pancreozymin. 
bee venom, thrcmbin. vasopressiti and fatly acids. It is also 
likely that the vasodilation that follows increased blood Row 
is an endothelium-derived relaxing factor-sediatcd response 
(3). Endathelium-derived relaxing factor appears to increase 
eeltutar guanytae eyclase (4). leading to an increase of cyclic 
guanosins 3’.5’ r&Phosphate (6MP) (S-71 and smooth 
vascular relaxation. The half-life of endothelium-derived 
glyccrm and nilroprwide relax vessels independently of 
e~iluihrlium-derived relaxing factor fas does prostacyclin 
,md illnal nntrweric factor). It has been known that organic 
nilrillCI Induce vo~cuiar relaxation and inhtbir platelet aggre- 
gauon by l”ErCBCi”g cellular zyctic GMP. It now uppcars IhA, 
cndorhclium-dctived relaxing factor for nitric oxide) is thr 
“endogenoos mtrate” that mediates vaaodilation induced by 
meny vasoactwe subslances. Exogenous organic nitratw 
cunvencly. probably directly release nitric oxide in the 
endothebum. leading to increased cyclic GMP and vasodila- 
lion. 
DilferenrS in hwnan and canine rqome5 ta nitroprustde 
and rdtroglywrin. How can the results of the study by Jet1 
et al. (91 in this issue of the Journal be reconciled in light of 
our current understanding of nitrate-smooth muscle pharma- 
cology? These authors have rcpxtcd that human intcmat 
mammary arteries, prerumahly free of atherosclerotic dis- 
ease and with intact intima. when contracted in vitro with 
pot;~wum and norepinephrinc were more responsive to the 
vasodilator properties of nitroPrusnide than to !hose of 
nitroglycerin. However, canine internal mammary arteries 
studied in viva demonstrated an effect contra-y to those 
obrerved m vnro; Row increased with nitroglycerin and 
decrcxed with nitropmsaide. Canine saphenous vein grafts 
studied in viva responded to oitroglycerin with a decrease in 
blood ROW and to nitroprussidc with 21 increase in blood 
flow. 
One simple explanation for these seemingly confusing 
results IS that in vitro studier in the human cannot be 
compared with in viva studies in the dog. Some more 
penetrating explanations, although rpeeulative, may also 
account fcr these di%erences. One porrioility is that the 
mtcrowcular responses to nitroprusside and nitroglycerin 
may vary in viva. Flow through the grafts may depend to 
home exteot on how the microvaxulature endotheliom re- 
spends IO nitroglycerin and nitmprosside. It is tiso possible 
that the kqe conduit vessels used in the in viva studier 
(internal mammary artery ami saphenous vein) have dif- 
ferent capabilities of generating endothelial cyclic GMP. 
given a equitmterd stimulus of nitric oxide. 
There may be intrinsic differences in the ability of oitro- 
glycerin and nitroprusaide 10 release nitric oxide, if indeed 
this is the mechanism whereby these agents increase cellular 
cyclic GMP. Spzecies differences in res~nsiveness to re- 
leased nitric oxide may account for the &tTerences between 
the human in vitro results and the canine in viva observa- 
tions. Lastly. it may not be appropriate to compare isolated 
vascular ings with vascular strucm~s of the intact circu!a- 
rian because Row irsclf may release endothetium-derived 
relaxing factor. 
Derpite these uncertainties, the observations of Jett and 
macolagy. The pieces ofihe puzzle still do no1 all come 4. Wrrtermlnn II. Mulsch A, Bobme 6. Bwsc R. Slimulation of soluble 
togelhcr. We shotiid look forward IO further progress from guanylatc cyclarc by acetytchatinckduccd cndnhrtium&riwd lvclor 
this group and others regarding this clitticolly relevant area 
from rabbit and canine arteries Circ Rcr WS638:13L8. 
of research. 
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